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Abstract
Background We hypothesised that different solutions for
submucosal injection may inﬂuence early healing of
endoscopic mucosal resection (EMR). The aim of this
study was to evaluate histological and immunological
changes after EMR in experimental pigs.
Materials and methods Two parallel EMRs on the ante-
rior and posterior wall of the gastric body were performed
by means of the cap technique in 21 female pigs. A glycerol-
based solution (anterior EMR) and hydroxypropyl
methylcellulose solution (posterior EMR) were applied for
submucosal injection. The animals were sacriﬁced 7 days
later, and tissue sections of all EMRs were stained using
combined trichrome. Computer image analysis was used
for objective evaluation of elastic and collagen ﬁbres
content. Two-colour indirect immunophenotyping of blood
and gastric samples were performed using mouse anti-pig
monoclonal antibodies.
Results The values of collagen ﬁbre content 7 days after
EMR were signiﬁcantly higher in lesions after the use of
solution A in comparison with solution B (2.10 ± 0.25%
versus 1.57 ± 0.25%, p = 0.009). Concordant results were
found in elastic ﬁbres (3.23 ± 0.49% versus 2.93 ±
0.61%, p = 0.018). No systemic changes in major leuko-
cyte subpopulations were found. In gastric tissue,
lymphocyte subsets exhibited only minor changes. CD4
?
T-lymphocytes were increased in the healing tissue after
EMR using solution A (17.08 ± 9.24% versus 9.76 ±
7.97%, p = 0.011). Signiﬁcant increase of SWC3
? leu-
kocytes was observed after EMR using solution B
(47.70 ± 25.41% versus 18.70 ± 12.16%, p = 0.001).
Conclusions The use of glycerol-based solution for sub-
mucosal injection was associated with more pronounced
histological signs of early healing of EMRs compared with
hydroxypropyl methylcellulose.
Keywords Submucosal injection  Healing 
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Endoscopic mucosal resection (EMR) has been widely used
as a therapeutic method for resection of nonpolypoid lesions
ofthegastrointestinaltract,mostlyofearlycancer[1].Itwas
originally developed in Japan for the purpose of obtaining a
larger biopsy specimen (strip-off biopsy) [2] and later
revised to its current form [3, 4]. Most EMR techniques
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DOI 10.1007/s00464-008-0207-3require use of submucosal injection to separate the lesion
from the muscularis propria and thus reduce thermal injury
and the risk of perforation and hemorrhage [1, 5–7].
In clinical endoscopy, numerous submucosal injection
solutions have been proposed for EMR (such as saline
solution with or without epinephrine, glucose, glycerol,
hyaluronic acid or autologous blood) [1, 8–18]. However,
no deﬁnitive proof of the superiority of any solution based
on comparative studies has been provided and thus no
conclusive recommendation for daily routine practice is
available.
Preclinical studies in an experimental setting enable
more detailed and precise evaluation as a paired arrange-
ment of different solutions in a single animal is possible (to
reduce interindividual variability), particular appraisal cri-
teria can be set in advance and followed (i.e. histology,
immunology, ﬁnal outcome etc.) and deﬁned variables can
be exactly determined (i.e. different viscosity, electrical
characteristics, injected volume etc.). In addition to this,
the small adult pig can be used in experiments as an
omnivorous representative due to its very similar gastro-
intestinal functions to man [19].
Previous studies of submucosal injection solutions for
EMR have mostly evaluated ability to create a submucosal
ﬂuid cushion and its duration. Most authors think that
sufﬁcient duration of lesion lifting is more important for
successful results of EMR than the types of solutions used
themselves. However, only a limited amount of attention
has been paid to the potential of injury to the muscularis
propria. Possible tissue damage of the muscularis propria
may result in impaired healing or even delayed complica-
tions (bleeding, perforation, stricture or stenosis) [20].
The overall objective of the present study was to evalu-
ate the early histological and immunological markers of
mucosal healing after gastric EMR in experimental pigs.
We hypothesised that different composition of solutions of
different viscosity used for submucosal injection could
inﬂuence the early healing of EMR.
Materials and methods
Animals
Twenty-one mature female pigs (Sus scrofa f. domestica),
hybrids of Czech White and Landrace breeds, weighing
34.1 ± 3.4 kg (4–5 months old), entered the study. They
were kept in air-conditioned rooms (22 ± 2C and
50 ± 10% relative humidity, with lights from 07:00 to
19:00 hours), fed twice a day (standard assorted food A1)
and allowed access to water ad libitum. Handling of
experimental animals was performed under the supervision
of the Institutional Board of Animal Care of the Institute of
Experimental Biopharmaceutics, Academy of Sciences of
the Czech Republic.
Drugs
All endoscopies were carried out under general anaesthesia.
Intramuscular injection of ketamine (20 mg/kg; Narkamon,
Spofa, Praha, Czech Republic), azaperone (2 mg/kg;
Stresnil, Janssen-Pharmaceutica, Beerse, Belgium) and
atropine (0.05 mg/kg; Atropin, Biotika, Slovenska ´ L ˇupc ˇa,
Slovakia)wasusedasaninduction,continuedbyinfusionof
1% thiopental (up to 25 mg/kg; Thiopental, Valeant Czech
Pharma, Praha, Czech Republic) administrated to the lateral
auricle vein.
Omeprazole (Zentiva, Praha, Czech Republic) was
administrated as an i.v. bolus (40 mg) at the end of
endoscopy to decrease the gastric production of hydro-
chloric acid and thus facilitate early healing of the base
after EMRs.
For the pharmacological euthanasia i.v. administration of
embutramide, mebezonium iodide and tetracaine hydro-
chloride (T61, Intervet International BV, Boxmeer, the
Netherlands; dose of 2 mL/kg) was used.
Solutions for submucosal injection
Two different solutions were used for submucosal injection
in each animal. Solution A contained 10% glycerol, 10%
glucose and 0.1% Patent Blue V (Guerbet, Roissy, France);
its viscosity was 1.69 mPa.s at 20C. Solution B contained
0.85% hydroxypropyl methylcellulose in Ringer solution
(Ivax Pharmaceuticals, Opava, Czech Republic), with a
viscosity of 20.0 mPa.s at 20C.
Endoscopy
All experiments were performed in the morning after
overnight fasting in an aseptic operating room. Endoscopy
procedures were performed using videogastroscopes GIF-
Q130 (Olympus Optical Co, Tokyo, Japan) dedicated for
animal use only. Two parallel standard EMRs on the
anterior and posterior wall of the gastric body were per-
formed by means of the cap technique in one session in all
animals. Transparent soft caps with a diameter of 17.2 mm
(MH 466, Olympus Optical Co, Tokyo, Japan) and EMR
polypectomy snares (SD-221U-25, Olympus Optical Co,
Tokyo, Japan) were used for EMRs. Solution A for the
anterior EMRs and solution B for the posterior EMRs were
applied; 10 mL of each solution was used for each sub-
mucosal injection. A 30-W seal cut (B Braun Aesculap,
Melsungen, Germany) was used for all EMRs. Mucosa
specimens were retrieved for subsequent histological and
immunological investigation. Submucosal tattooing using a
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Supply, Camp Hill, USA) was performed close (about
2 cm) to EMR with solution A on the anterior gastric wall.
Each couple of EMRs in a single animal was performed by
the same endoscopist (J.B. or M.K.). All endoscopies were
video-recorded on digital versatile disk (DVD).
Animals were allowed food and water immediately after
their recovery from general anaesthesia. Seven days later,
the pigs were sacriﬁced by means of pharmacological
euthanasia. Immediate autopsy was performed. Macro-
photographs of the stomach with healing EMRs were taken
and afterwards specimens of the gastric body were
obtained at autopsy for subsequent analysis.
A 7-day interval was chosen based on results of a pilot
testing EMRs performed previously in four animals with
subsequent histological analysis of healing of EMRs on
days 3, 5, 7, and 11.
Histology
ThepartsofgastricmucosaobtainedbymeansofEMR(two
samples from each animal) and specimens of gastric body at
the area of previous EMR 7 days later (two samples from
each animal) were carefully ﬁxed with 10% neutral buffered
formalin. Samples were subsequently embedded into par-
afﬁn, 1-lm-thick tissue sections were cut and Gram staining
for bacteria as well as combined trichrome (green trichrome
with Orange Q) staining were provided.
Image analysis
StainedsampleswereevaluatedbyusingBX-51microscope
(Olympus Optical Co, Tokyo, Japan) and ImagePro 5.1
computer image analysis (Media Cybernetics, Bethesda,
USA). Six microscopic ﬁelds with a size of 20,000 lm
2 at
6009 original magniﬁcation were randomly selected from
each sample for evaluation of elastic and collagen ﬁbres
content. The positive RGB structures were detected in the
range: red,green, andblue forelastic ﬁbres, where 0isblack
and 255 is white as well as inverted RGB in the range: red,
green, and blue detecting collagen ﬁbres, where 0 is white
and 255 is black. The percentage positivity of the viewing
ﬁelds was subsequently measured. Percentage positivity
means the percentage of positive objects.
Immunophenotyping of cells
Blood samples
Heparinised peripheral blood was obtained from vena
cava cranialis just before EMR and 7 days later before
pharmacological euthanasia in all experimental animals.
Erythrocytes were removed using EasyLyse (Dako,
Glostrup, Denmark) lysing solution according to the
manufacturer’s instructions. Remaining leukocytes were
washed twice by means of centrifuging and resuspending
the pellet in an ice-cold washing and staining buffer (WSB,
phosphate-buffered saline containing 0.1% sodium azide
and 0.02% gelatine from cold water ﬁsh skin, all reagents
from Sigma-Aldrich, St. Louis, USA). Cells were counted
and their density was set to 5 9 10
6 per mL.
Gastric samples
Gastric mucosa was obtained by means of EMR using
either solution A or B. The samples from the healing
lesions were excised at autopsy. Mucus was removed from
the tissue by means of washing with phosphate-buffered
saline and the cells from the superﬁcial part of the tissue
were released by gentle scraping using a scalpel; tissue
aggregates were homogenised by pipetting. The suspension
was then ﬁltered through a ﬁne nylon mesh and washed
twice in ice-cold WSB, cells were counted and their den-
sity was set to 5 9 10
6 per mL. All samples were kept on
ice until immunostaining.
Cell staining
Two-colour indirect immunophenotyping was performed
as described elsewhere [21]. Brieﬂy, 100 lL of the cell
suspension (5 9 10
6 cells) was incubated for 30 min with a
pair of optimally titrated mouse anti-pig monoclonal anti-
bodies of different (sub)isotypes in 96-well microtitration
plates, washed twice in WSB and Fc receptors on the cell
surface were subsequently blocked by incubating the cells
in WSB containing 10% heat inactivated nonimmune
normal goat serum. After another centrifugation step, the
binding of primary immunoreagents was visualised by
resuspending the cells in WSB containing an appropriate
cocktail of ﬂuorescein isothiocyanate and phycoerythrin-
conjugated goat anti-mouse polyclonal antisera speciﬁc for
mouse Ig (sub)isotypes (Southern Biotech, Birmingham,
USA). After 20 min of incubation the cells were washed
twice in WSB. The panel of the following mouse anti-pig
monoclonal antibodies was used: anti-CD45 (K252.1E4,
IgG1), anti-CD2 (MSA4, IgG2a), anti-CD3e (PPT3, IgG1),
anti-CD4 (10.2H2, IgG2b), anti-CD8 (76-2-11, IgG2a),
anti-TCRcd (PPT16, IgG2b), anti-SWC3a (74-22-15,
IgG2b) and anti-IgM (Lig4, IgG1).
Flow cytometry
The samples were acquired on a CyAn ADP analyser
(Dako, Glostrup, Denmark) and 30,000–500,000 events
were collected in each sample depending on leukocyte
proportions. Damaged and dead cells were excluded from
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123analysis using propidium iodide (10 lL/mL) ﬂuorescence.
Data analysis was performed using Summit 4.3 software
(Dako, Glostrup, Denmark).
Statistical analysis
Data were statistically analysed with paired t-test and
Mann–Whitney rank-sum test. The second-type error b was
calculated when appropriate. Statistical software used for
these analyses was SigmaStat version 3.1 (Jandel Corp,
Erkrath, Germany). A p-value of less than 0.05 was
accepted as statistically signiﬁcant.
Ethics
The study was approved by the Institutional Review Board
of Animal Care Committee of the Institute of Experimental
Biopharmaceutics, Academy of Sciences of the Czech
Republic, Protocol Number 149/2006. Animals were held
and treated in accordance with the European Convention
for the Protection of Vertebrate Animals Used for Expe-
rimental and Other Scientiﬁc Purposes [22].
Results
Histology and image analysis
There was no gross complication of the EMR itself in any
animal (Fig. 1). No presence of bacterial infection in any
sample (as a complication of EMR) was found in histology.
The results of quantitative histological detection of com-
bined trichrome staining of granulous tissue in the healing
lesions of the gastric wall after EMRs are shown in
Table 1. The values of elastic ﬁbre content 7 days after
EMR were signiﬁcantly higher in lesions after the use of
solution A in comparison with after use of solution B
(Figs. 2 and 3). The same results were observed during
measuring of content of collagen ﬁbres. Lesions after EMR
using solution A expressed a higher percentage of collagen
ﬁbres than those having used the solution B for submucosal
injection before EMRs (Figs. 4 and 5).
Leukocyte population and lymphocyte subsets analysis
No systemic changes in major leukocyte populations,
lymphocyte subpopulations and their subsets were found
during the experiment. As typical for an outbred popula-
tion, individual pigs differed in the proportions of major
lymphocyte subpopulations and subsets in peripheral blood
and the gastric EMR did not cause any signiﬁcant changes
or trends in circulation. Well-deﬁned lymphocyte subsets
such as CD4
?CD8
? double-positive T cells, CD4
-CD8
?
and CD4
?CD8
- cytotoxic and helper/regulatory ab T
cells, respectively, CD3
-CD8
? NK cells, TCRcd
? T cells
Fig. 1 Representative view of two healing lesions 7 days after
EMRs. The posterior wall is on the left and the anterior one on the
right. Submucosal tattooing by suspension of highly puriﬁed carbon
particles is marked by an asterisk
Table 1 Content of collagen and elastic ﬁbres in granulous tissue
7 days after EMR, in percent mean ± standard error on the mean
(SEM)
Parameter Solution A Solution B Signiﬁcance
Collagen ﬁbres 2.10 ± 0.25 1.57 ± 0.25 p = 0.009*
Elastic ﬁbres 3.23 ± 0.49 2.93 ± 0.61 p = 0.018*
* Mann–Whitney rank-sum test
Fig. 2 Detailed view of granulous tissue (magniﬁcation 6009)
7 days after EMR in the stomach (solution A). Elastic ﬁbres are
bright violet (arrows). Combined trichrome (green trichrome with
Orange Q) staining
Surg Endosc (2009) 23:2094–2101 2097
123or B cell subsets differing in CD2 expression exhibited
only minor changes typical for different collection days in
individual pigs (data not shown). Similar to lymphocytes,
analysis of myelomonocytic cells in peripheral blood did
not reveal any reproducible changes before and 7 days
after EMR.
In gastric samples, the CD4
? single-positive T-cells
appeared to increase their relative numbers in the healing
wound 7 days after the submucosal injection of solution A
(9.76 ± 7.97% versus 17.08 ± 9.24%, p = 0.011). In tissue
samples, a signiﬁcant increase of the proportion of SWC3
?
leukocyteswasobservedonday7(comparedwithday1)after
the submucosal injection of solution B (18.70 ± 12.16%
versus 47.70 ± 25.41%, p = 0.001). ResultswithsolutionA
appeared to have a similar trend but the difference between
day 1 and 7 was not statistically signiﬁcant. There was no
signiﬁcantdifferencein the proportionofSWC3
? leukocytes
onday7aftertheuseofsolutionsAorB(p = 0.129;powerof
the performed test 0.198). Scatter characteristics of the
myelomonocytic (SWC3
?) population that enlarged its size
after EMR suggested that such cells were granulocytes (high
side scatter values).
Overall healing characteristics
The results of particular parameters displayed above
clearly show that different solutions used for submucosal
injection before EMR inﬂuenced early signs of healing
assessed by histology. The use of the glycerol-based
solution was associated with more pronounced histological
signs of early healing compared with the solution of
hydroxypropyl methylcellulose. There were no signiﬁcant
changes of major leukocyte populations, lymphocyte sub-
populations and myelomonocytic cells in peripheral blood
as a systemic response 7 days after EMRs. The increased
myelomonocytic population in the healing lesion after
EMR were granulocytes.
Discussion
In this study, we compared different solutions used for
submucosal injection and evaluated their impact on early
mucosal healing after gastric EMR in experimental pigs.
The use of the glycerol-based solution was associated with
more pronounced histological signs of early healing com-
pared with the solution of hydroxypropyl methylcellulose.
Both solutions are highly hydrophilic but they markedly
differed in their viscosity. However, the possible beneﬁcial
mechanism of glycerol-based solution in the early stage of
healing after EMR remains unclear. Uraoka et al. [12]
Fig. 3 Detailed view of granulous tissue (magniﬁcation 6009)
7 days after EMR in the stomach (solution B). Elastic ﬁbres are
bright violet (arrows). Combined trichrome (green trichrome with
Orange Q) staining
Fig. 4 Inverted image of Fig. 2, demonstrating numerous collagen
ﬁbres in dark brown (arrows)
Fig. 5 Inverted image of Fig. 3, demonstrating numerous collagen
ﬁbers in dark brown (arrows)
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with colorectal laterally spreading tumours. Glycerol
provided a better resection rate but there was only a
positive trend to parallel lower local recurrence rate (sta-
tistically not signiﬁcant) [12]. Feitoza et al. [23] tested
hydroxypropyl methylcellulose in experimental pigs.
Hydroxypropyl methylcellulose was injected into the
oesophageal submucosa (no subsequent EMRs were done).
Histologic ﬁndings were fully normal only at 6% of the
sites. Histology demonstrated negligible alterations in 33 of
36 (92 %) places, including the presence of a minimal
amount of residual hydroxypropyl methylcellulose [23]. As
no EMR was performed, this study could be compared only
partly with our experiment. Nevertheless, deeper injection
could administrate some hydroxypropyl methylcellulose
into the muscular layer or even to the adventitia/serosa.
Mucosal wound healing is a complex process. The ini-
tial stage of healing within the ﬁrst 24 h is characterised
mostly by substantial inﬁltrate of neutrophils. By days 3–5,
neutrophils have been largely replaced by monocyte–
macrophage lines and ﬁbroblasts, and granulation tissue
progressively invades the healing area. Migration and
proliferation of both parenchymal and connective tissue
cells have been augmented [24]. Adequate reconstitution
requires the coordinated interaction of endothelial cells and
ﬁbroblasts during the proliferation phase of healing.
Endothelial cells assure neoangiogenesis, ﬁbroblasts ﬁll the
defect and provide extracellular matrix proteins, and
myoﬁbroblasts are believed to support the reconstitution of
microvessels [25]. The extracellular matrix is constituted
by collagen and elastic ﬁbres, proteoglycans (heparan
sulphates), adhesive glycoproteins (ﬁbronectin) and inte-
grins. By the end of the ﬁrst week, there is continued
collagen accumulation and ﬁbroblast proliferation. The
leukocyte inﬁltrate and increased vascularity are substan-
tially diminished [24]. At this stage, collagen and elastic
ﬁbres are the most relevant markers of healing. In our study
1 week after EMR, we found a signiﬁcantly higher content
of both collagen and elastic ﬁbres in healing lesions having
used solution A (glycerol-based) for submucosal injection
for EMR compared with solution B (containing hydroxy-
propyl methylcellulose). This exact assessment was made
possible owing to objective image analysis using computer
software. Such an evaluation would not be conceivable
with the naked eye. Both EMR lesions were of the same
size, made in the gastric body during the same session in all
animals, and thus fully comparable.
Studies in healing of gastric ulcers showed that extra-
cellular matrix components (procollagens, collagen type I,
III and IV, laminin, ﬁbronectin) play an important role in
attachment, migration and repair of wounded cultured
gastric epithelial cells [26], in experimental animals [27]
and in healing of gastric ulcers in humans [28, 29].
The leukocyte compartment in the blood and gastric
tissue at the site of treatment was determined by double
colour immunophenotyping and ﬂow cytometry at the time
of the submucosal injection of particular solutions for EMR
(either A or B) and 7 days later. The samples of gastric
mucosa obtained by means of EMR and healing lesions
collected at autopsy 7 days later were histologically dif-
ferent. While gastric samples from the beginning of the
experiment mostly consisted of undamaged layer of
mucosa containing only a few intraepithelial lymphocytes
and a population of lamina propria lymphocytes with
TCRab
? T-cells and TCRcd
? T cells possessing the CD4
?
and/or CD8
? surface phenotype and some NK cells [30],
the healing gastric lesion 7 days after EMR was inﬁltrated
by increased numbers of myelomonocytic cells in both
samples, which corresponded to the healing process within
the mucosal layer. The slightly increased relative numbers
of CD4
? single-positive T-cells at the site of EMR 7 days
after the endoscopy may reﬂect the recruitment from cir-
culation of helper/regulatory T lymphocytes with a
possible role in regulating the healing process via the
cytokine network. The accumulation of myelomonocytic
cells within the damaged tissue is a typical example of
monocyte and granulocyte recruitment during the inﬂam-
matory and healing process, where such cells play an
important role in the tissue repair process [31]. In our
setting, there was no signiﬁcant difference in the proportion
of SWC3
? leukocytes in the healing lesion after EMRs on
day 7 between the use of solutions A and B for submucosal
injection. However, the power of the performed test (0.198)
was below the desired power of 0.800. This could indicate
that we were more likely not to detect a difference when
one actually existed. This is why it is necessary to be
cautions in overinterpreting the lack of difference found
here. We hypothesise that the difference could be identiﬁed
some time earlier. Lower proportions of B cells in the
gastric samples (less than 5% of lymphocytes when com-
pared with the circulation where typically more than 10%
of sIgM
? lymphoid cells were present) is typical for lym-
phocyte subset composition of suspension isolated from
nonlymphatic tissues.
One possible limitation of our current study is that it did
not deal with the ﬁnal outcome of EMR. Kamler et al. [32]
performed circumferential oesophageal EMRs in experi-
mental pigs. Saline solution was used for submucosal
injection. Oesophageal strictures developed in three of
eight animals over 3–5 weeks [32]. Thus we can speculate
whether different solutions for submucosal injection would
inﬂuence not only early healing but also ﬁnal outcome of
EMR. However, in the early stage of wound healing
(within the ﬁrst 14 days), presence of collagen (together
with elastic ﬁbres and granulous tissue) is not related to
scar formation. At this stage, collagen and elastic ﬁbres are
Surg Endosc (2009) 23:2094–2101 2099
123the most relevant markers of healing. Last but not least, we
do not think that blood supply would inﬂuence the rate of
healing (i.e. content of collagen and elastic ﬁbres). The
porcine gastric fundus is larger compared to the human
one, supplied mostly by the left gastric artery [33]. How-
ever, there is no difference in blood supply of the anterior
and posterior walls of the porcine gastric body [34, 35],
accounting for half of total gastric blood ﬂow [36]. The
fundus and gastric body can be easily recognised and dis-
tinguished at gastroscopy with a clear sharp borderline
(mucosa of the gastric fundus is markedly darker). All
EMRs in our study were placed in the central part of the
gastric body.
In conclusion, both glycerol- and hydroxypropyl-
methylcellulose-based solutions provided optimal lifting of
the mucosa before EMRs. The use of glycerol-based
solution for submucosal injection was associated with more
distinct signs of early healing in experimental pigs.
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